These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 22166714)

  • 1. Analysis of the efficacy of screening tests in colorectal cancer by faecal occult blood test--own experience.
    Kozłowski T; Godlewski D; Biczysko M; Grochowalski M; Nelke M; Paszkowski J; Borejsza-Wysocki M; Krokowicz L; Krokowicz P; Banasiewicz T; Drews M
    Pol Przegl Chir; 2011 Aug; 83(8):411-23. PubMed ID: 22166714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of usefulness of faecal occult blood test. Prospective screening study in patients with colorectal neoplasia].
    Banaszkiewicz Z; Jawień A; Jarmocik P; Tojek K; Jankowski M; Switoński M
    Pol Merkur Lekarski; 2004 Dec; 17(102):579-82. PubMed ID: 15771126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of diagnostic examinations for colorectal polyps.
    Menardo G
    Tech Coloproctol; 2004 Dec; 8 Suppl 2():s273-5. PubMed ID: 15666105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal carcinoma screening procedure use among primary care patients.
    Lafata JE; Williams LK; Ben-Menachem T; Moon C; Divine G
    Cancer; 2005 Oct; 104(7):1356-61. PubMed ID: 16092119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal occult blood and flexible sigmoidoscopy screening for colorectal cancer: modeling the impact on colonoscopy requirements and cancer detection rates.
    Olynyk JK; Platell CF; Collett JA
    J Gastroenterol Hepatol; 2001 Apr; 16(4):389-92. PubMed ID: 11354276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of undetected ulcerative colitis: data from the Nottingham fecal occult blood screening trial.
    Howarth GF; Robinson MH; Jenkins D; Hardcastle JD; Logan RF
    Am J Gastroenterol; 2002 Mar; 97(3):690-4. PubMed ID: 11926210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Colorectal cancer: study on 365 cases].
    Celestino A; Castillo T; Frisancho O; Contardo C; Espejo H; Tomioka C; Navarrete J
    Rev Gastroenterol Peru; 1996; 16(3):187-96. PubMed ID: 12165782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal carcinoma: is screening possible?
    Bonelli L
    Tech Coloproctol; 2004 Dec; 8 Suppl 2():s267-72. PubMed ID: 15666104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Colorectal cancer screening: where are we and where are we going?].
    Fantin A; Chiarioni G
    Recenti Prog Med; 2013 Feb; 104(2):45-8. PubMed ID: 23535955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonoscopy: a review of its yield for cancers and adenomas by indication.
    Rex DK
    Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The case for population-based screening for colorectal cancer.
    Schoen RE
    Nat Rev Cancer; 2002 Jan; 2(1):65-70. PubMed ID: 11902587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer: risk factors and recommendations for early detection.
    Read TE; Kodner IJ
    Am Fam Physician; 1999 Jun; 59(11):3083-92. PubMed ID: 10392591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement.
    Ko CW; Kreuter W; Baldwin LM
    BMC Gastroenterol; 2005 Mar; 5():10. PubMed ID: 15755323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.
    Daniels K; McKee M
    J R Army Med Corps; 1995 Oct; 141(3):142-50. PubMed ID: 8568748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
    El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
    Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
    Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
    Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for colorectal cancer in elderly persons and possible methodologies for their screening.
    Rozen P; Shabtai EI; Liphshitz I; Barchana M
    Eur J Gastroenterol Hepatol; 2011 May; 23(5):431-7. PubMed ID: 21448071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of colorectal diseases in immunological fecal occult blood test (I-FOBT) positive patients in a tertiary care hospital in Bangladesh.
    Mollick SH; Roy PK; Bhuiyan MR; Mia AR; Alam MS; Mollick KA; Pervin S; Hassan MQ
    Mymensingh Med J; 2014 Oct; 23(4):764-9. PubMed ID: 25481598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.